Clik here to view.
Three dealmaking trends to look for in 2011
The relationship between the biotechnology and pharmaceutical industries has never been clearer – partner to survive. The Business Forum at the 2011 BIO International Convention is the world’s largest...
View ArticleClik here to view.
BioCentury TV at BIO International Convention
BioCentury TV interviewed biotech leaders throughout the recent BIO International Convention in Washington, DC. The first interview can be found here (links to the other interviews can be found on the...
View ArticleClik here to view.
Perspective on Market Valuation for Biotech Drug Developers
Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% are working on molecular tools, diagnostics, biofuels, and other biotech endeavors. One question that is often...
View ArticleClik here to view.
Pharmaceuticals Play a Key Role in Value-Based Care
By Dan Leonard, President, National Pharmaceutical Council Public and private sector health care stakeholders have been struggling with how best to achieve the triple aim of better care for...
View ArticleClik here to view.
Blaming Pharma Won’t Lower Health Care Costs
This week, the USA Today Editorial Board took aim at the pharmaceutical industry in a new piece: Stop Big Pharma from ‘getting away with murder’. After digging into the data, we found several factual...
View Article
